EP0627930A4 - Composition and method of treating hepatitis b. - Google Patents
Composition and method of treating hepatitis b.Info
- Publication number
- EP0627930A4 EP0627930A4 EP93917072A EP93917072A EP0627930A4 EP 0627930 A4 EP0627930 A4 EP 0627930A4 EP 93917072 A EP93917072 A EP 93917072A EP 93917072 A EP93917072 A EP 93917072A EP 0627930 A4 EP0627930 A4 EP 0627930A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- composition
- treating hepatitis
- hepatitis
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91467392A | 1992-07-13 | 1992-07-13 | |
US914673 | 1992-07-13 | ||
PCT/US1993/006485 WO1994001125A1 (en) | 1992-07-13 | 1993-07-09 | Composition and method of treating hepatitis b |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0627930A1 EP0627930A1 (en) | 1994-12-14 |
EP0627930A4 true EP0627930A4 (en) | 1997-08-20 |
Family
ID=25434648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP93917072A Withdrawn EP0627930A4 (en) | 1992-07-13 | 1993-07-09 | Composition and method of treating hepatitis b. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0627930A4 (en) |
CN (1) | CN1087829A (en) |
AU (1) | AU4671193A (en) |
MX (1) | MX9304209A (en) |
WO (1) | WO1994001125A1 (en) |
ZA (1) | ZA935055B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6200952B1 (en) | 1993-06-02 | 2001-03-13 | Sciclone Pharmaceuticals, Inc. | Combination therapy method for treating chronic hepatitis B |
CA2175337C (en) * | 1993-11-05 | 2000-06-20 | Paul B. Chretien | Method and composition for treatment of patients having decompensated liver disease |
US6199073B1 (en) | 1997-04-21 | 2001-03-06 | Ricoh Company, Ltd. | Automatic archiving of documents during their transfer between a peripheral device and a processing device |
US5939423A (en) * | 1997-04-16 | 1999-08-17 | Sciclone Pharmaceuticals, Inc. | Treatment of hepatitis B infection with thymosin alpha 1 and famciclovir |
US6288033B1 (en) | 1998-09-25 | 2001-09-11 | Sciclone Pharmaceuticals, Inc. | Treatment of hepatitis B infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir |
WO2010129947A2 (en) | 2009-05-08 | 2010-11-11 | Sciclone Pharmaceuticals, Inc. | Alpha thymosin peptides as vaccine enhancers |
ES2527544T1 (en) | 2011-10-21 | 2015-01-26 | Abbvie Inc. | Mono treatment (PSI-7977) or combination with ADF for use in the treatment of HCV |
US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
AR088463A1 (en) | 2011-10-21 | 2014-06-11 | Abbvie Inc | METHODS FOR HCV TREATMENT |
US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
CN103494769B (en) * | 2013-10-08 | 2015-12-23 | 深圳翰宇药业股份有限公司 | A kind of compound long-acting in-situ gel injection agent for the treatment of chronic viral hepatitis B and preparation method thereof |
WO2017189978A1 (en) | 2016-04-28 | 2017-11-02 | Emory University | Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
CN111450240A (en) * | 2020-04-27 | 2020-07-28 | 浙江大学 | Application of combination of small molecule compound M L N4924 and IFN α in anti-HBV |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0357571A2 (en) * | 1988-06-10 | 1990-03-07 | Medivir Aktiebolag | Pyrimidine nucleosides |
WO1993005806A1 (en) * | 1991-09-13 | 1993-04-01 | Alpha 1 Biomedicals, Inc. | Composition and method of treating hepatitis c |
WO1996000573A1 (en) * | 1994-06-30 | 1996-01-11 | Bio-Logic Research And Development Corporation | Compositions for enhancing immune function |
-
1993
- 1993-07-09 AU AU46711/93A patent/AU4671193A/en not_active Abandoned
- 1993-07-09 EP EP93917072A patent/EP0627930A4/en not_active Withdrawn
- 1993-07-09 WO PCT/US1993/006485 patent/WO1994001125A1/en not_active Application Discontinuation
- 1993-07-13 MX MX9304209A patent/MX9304209A/en active IP Right Grant
- 1993-07-13 CN CN93116777A patent/CN1087829A/en active Pending
- 1993-07-13 ZA ZA935055A patent/ZA935055B/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0357571A2 (en) * | 1988-06-10 | 1990-03-07 | Medivir Aktiebolag | Pyrimidine nucleosides |
WO1993005806A1 (en) * | 1991-09-13 | 1993-04-01 | Alpha 1 Biomedicals, Inc. | Composition and method of treating hepatitis c |
WO1996000573A1 (en) * | 1994-06-30 | 1996-01-11 | Bio-Logic Research And Development Corporation | Compositions for enhancing immune function |
Non-Patent Citations (1)
Title |
---|
See also references of WO9401125A1 * |
Also Published As
Publication number | Publication date |
---|---|
ZA935055B (en) | 1995-04-13 |
EP0627930A1 (en) | 1994-12-14 |
MX9304209A (en) | 1994-04-29 |
AU4671193A (en) | 1994-01-31 |
WO1994001125A1 (en) | 1994-01-20 |
CN1087829A (en) | 1994-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA947354B (en) | Composition and process for treating metal | |
AP9300598A0 (en) | Compositions and method for waste treatment | |
EP0717592A4 (en) | Method and composition for the treatment of apathy-amotivation syndrome | |
ZA949346B (en) | Composition and process for treating metal | |
EP0556447A3 (en) | Surfactant composition and method of making the same | |
EP0579453A3 (en) | Masonry treating composition and method. | |
EP0627930A4 (en) | Composition and method of treating hepatitis b. | |
ZA931778B (en) | Method and composition for the treatment of osteoporosis | |
ZA948252B (en) | Method and composition for treatment of autoimmune hepatitis | |
GB9014307D0 (en) | Method of treatment and compositions therefor | |
IL105217A0 (en) | Method and composition for treating acne | |
AU9087591A (en) | Composition and method for treating metal | |
GB9224295D0 (en) | Method and composition | |
EP0454169A3 (en) | Photomask and method of treating the same | |
GB9202196D0 (en) | Method of treatment | |
EP0611214A3 (en) | Acidic composition and process of using same. | |
EP0717622A4 (en) | Methods of treating hiv with azaspiranes | |
ZA939171B (en) | Composition and process for treating tinplate | |
AU6559194A (en) | Method of treating hepatitis b infection | |
SG54220A1 (en) | Composition and process for treating metal | |
CS61691A2 (en) | Composition for dung-water treatment and method of dung-water treatment | |
AU5467198A (en) | Composition and method of treating hepatitis B | |
GB9026896D0 (en) | Method and composition | |
GB9201391D0 (en) | Method of treatment | |
PL289358A1 (en) | Posticide and method of treating soil therewith |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19970703 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
17P | Request for examination filed |
Effective date: 19940927 |
|
17Q | First examination report despatched |
Effective date: 19980401 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19990223 |